These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8459640)

  • 1. Antitumor effect and survival benefit of chemotherapy for unresectable advanced gastric cancer.
    Kiyohashi A; Kurihara M; Yoshida S; Ohkubo T; Suga S
    Jpn J Clin Oncol; 1993 Feb; 23(1):41-5. PubMed ID: 8459640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy].
    Sakata Y; Chiba Y; Sato T; Kimura M; Fukushi G; Matsukawa M; Wada K; Aoyama H; Sawada Y; Fukushi M
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):195-201. PubMed ID: 1736831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Randomized controlled trial of MMC + UFT and MMC + 5-FU therapy in advanced gastric cancer].
    Sasagawa T; Ho N; Endo T; Sekine T; Sugiyama K; Tomidokoro T; Hatakeyama S; Togashi M; Onuki K; Katagiri J
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1179-85. PubMed ID: 8031159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
    Arima S; Yamamoto H; Hisatsugu T; Ohkuma R; Ohsato K; Abe R; Nakamura Y; Fukuyama N; Yamanouchi A; Taira A
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):443-9. PubMed ID: 1900685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of an aged woman with advanced gastric cancer which dramatically responded to combined chemotherapy with UFT and mitomycin C].
    Adachi M; Sasaki M
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2856-7. PubMed ID: 3092746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy].
    Shinoda M; Morise K; Kusugami K; Iwase H; Ina K; Kaneko H; Horiuchi Y; Kuroiwa A; Suga S; Oka Y
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):515-20. PubMed ID: 7887643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of UFT in advanced gastric carcinoma under comparative study of MMC + UFT and MMC + tegafur therapies].
    Inoue Y; Nasu H; Nakamura J; Arakawa H; Masamune O; Yamada N; Furuya M; Ookubo M; Mukojima T; Koizumi R
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3567-72. PubMed ID: 2510604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
    Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
    Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre randomised study of adjuvant chemotherapy with mitomycin C and tegafur or tegafur-uracil in gastric cancer.
    Arima S; Ohsato K; Hisatsugu T; Shimura H
    Eur J Surg; 1994 Apr; 160(4):227-32. PubMed ID: 8049313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
    Nakata K; Shigemitsu M; Joya K; Sato K; Hara S; Hanawa S
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1694-6. PubMed ID: 3927850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer--a single institute study.
    Nio Y; Koike M; Omori H; Hashimoto K; Itakura M; Yano S; Higami T; Maruyama R
    Anticancer Res; 2004; 24(3b):1879-87. PubMed ID: 15274369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of Borrmann's type IV diffuse carcinoma of the stomach].
    Suga S; Kimura K; Yokoyama Y
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2478-84. PubMed ID: 6418076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined UFTM for 140 patients with advanced gastric cancer].
    Jin ML
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):130-2. PubMed ID: 2553364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [UFT + MMC and UFT + ACNU therapy in advanced gastric cancer].
    Sasai T; Kurihara M; Kubo Y; Nakano S; Kamano T; Taguchi S; Fukuyama E; Suwa T; Miyoshi K; Oda K
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):141-6. PubMed ID: 3122666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer.
    Chen JS; Rau KM; Chen YY; Huang JS; Yang TS; Lin YC; Liau CT; Lee KD; Su YC; Kao RH
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):819-25. PubMed ID: 18663448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multihospital randomized study on adjuvant chemotherapy with mitomycin C and futraful or UFT in gastric cancer (Part 1). Comparison between futraful and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy)].
    Arima S; Simura H; Yamanouchi A; Fukuyama N; Hisatsugu T; Yamamoto H; Ohsato K; Ohkuma R; Nakamura Y; Abe R
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2524-31. PubMed ID: 3113340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of the histoculture drug-response assay to contribute to cancer patient survival.
    Kubota T; Sasano N; Abe O; Nakao I; Kawamura E; Saito T; Endo M; Kimura K; Demura H; Sasano H
    Clin Cancer Res; 1995 Dec; 1(12):1537-43. PubMed ID: 9815954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients.
    Yonemura Y; Kinoshita K; Fujimura T; Fushida S; Sawa T; Matsuki N; Tanaka S; Kamata T; Takashima T; Miyazaki I
    Hepatogastroenterology; 1996; 43(11):1260-72. PubMed ID: 8908561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An unresectable gastric cancer radically resectable following UFT, ADM, MMC therapy].
    Watarai N; Kataoka M; Hayashi S; Tsuji H; Kasugai T; Taniwaki S; Kureyama Y; Mitsui T; Masaoka A; Kamejima N
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3467-71. PubMed ID: 2508569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [UFT-therapy and UFTM therapy--comparison of survivals in the patients with Borrmann type 4 gastric cancer treated either with UFTM-chemotherapy or operation].
    Suga S; Kimura K; Yokoyama Y
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):769-74. PubMed ID: 6424582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.